These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 38211611)
1. Biosimilars: From Production to Patient. Sheridan M; Massich M; Ashourian N J Infus Nurs; 2024 Jan-Feb 01; 47(1):19-29. PubMed ID: 38211611 [TBL] [Abstract][Full Text] [Related]
2. Optimizing use and addressing challenges to uptake of biosimilars. Leber MB Am J Manag Care; 2018 Nov; 24(21 Suppl):S457-S461. PubMed ID: 30452214 [TBL] [Abstract][Full Text] [Related]
3. Biosimilars in Oncology in the United States: A Review. Nabhan C; Parsad S; Mato AR; Feinberg BA JAMA Oncol; 2018 Feb; 4(2):241-247. PubMed ID: 28727871 [TBL] [Abstract][Full Text] [Related]
4. Biosimilars-Emerging Role in Nephrology. Wish JB Clin J Am Soc Nephrol; 2019 Sep; 14(9):1391-1398. PubMed ID: 30082337 [TBL] [Abstract][Full Text] [Related]
6. Clinical considerations for the development of biosimilars in oncology. Socinski MA; Curigliano G; Jacobs I; Gumbiner B; MacDonald J; Thomas D MAbs; 2015; 7(2):286-93. PubMed ID: 25621390 [TBL] [Abstract][Full Text] [Related]
7. Biosimilar biologic drugs: a new frontier in medical care. Geynisman DM; De Velasco G; Sewell KL; Jacobs I Postgrad Med; 2017 May; 129(4):460-470. PubMed ID: 28343424 [TBL] [Abstract][Full Text] [Related]
8. Pharmacist perspectives and considerations for implementation of therapeutic oncology biosimilars in practice. Cuellar S; McBride A; Medina P Am J Health Syst Pharm; 2019 Oct; 76(21):1725-1738. PubMed ID: 31612935 [TBL] [Abstract][Full Text] [Related]
9. Biosimilars 101: considerations for U.S. oncologists in clinical practice. Camacho LH; Frost CP; Abella E; Morrow PK; Whittaker S Cancer Med; 2014 Aug; 3(4):889-99. PubMed ID: 24810680 [TBL] [Abstract][Full Text] [Related]
10. A Systematic Review of U.S. Biosimilar Approvals: What Evidence Does the FDA Require and How Are Manufacturers Responding? Hung A; Vu Q; Mostovoy L J Manag Care Spec Pharm; 2017 Dec; 23(12):1234-1244. PubMed ID: 29172975 [TBL] [Abstract][Full Text] [Related]
12. Assessment of Availability, Clinical Testing, and US Food and Drug Administration Review of Biosimilar Biologic Products. Moore TJ; Mouslim MC; Blunt JL; Alexander GC; Shermock KM JAMA Intern Med; 2021 Jan; 181(1):52-60. PubMed ID: 33031559 [TBL] [Abstract][Full Text] [Related]
13. Current market and regulatory landscape of biosimilars. Bhatt V Am J Manag Care; 2018 Nov; 24(21 Suppl):S451-S456. PubMed ID: 30452213 [TBL] [Abstract][Full Text] [Related]
14. The complexities of biosimilars and the regulatory approval process. Lucio S Am J Manag Care; 2018 Jun; 24(11 Suppl):S231-S236. PubMed ID: 29957908 [TBL] [Abstract][Full Text] [Related]
15. Overview of biosimilars for immune-mediated inflammatory diseases: summary of current evidence. Strand V; Evans C; Gibofsky A Am J Manag Care; 2022 Nov; 28(12 Suppl):S217-S226. PubMed ID: 36493395 [TBL] [Abstract][Full Text] [Related]
16. Regulatory and cost barriers are likely to limit biosimilar development and expected savings in the near future. Grabowski HG; Guha R; Salgado M Health Aff (Millwood); 2014 Jun; 33(6):1048-57. PubMed ID: 24889955 [TBL] [Abstract][Full Text] [Related]
17. The cost savings of biosimilars can help increase patient access and lift the financial burden of health care systems. Kvien TK; Patel K; Strand V Semin Arthritis Rheum; 2022 Feb; 52():151939. PubMed ID: 35027243 [TBL] [Abstract][Full Text] [Related]
18. Biosimilars: Here and Now. Lemery SJ; Esteva FJ; Weise M Am Soc Clin Oncol Educ Book; 2016; 35():e151-7. PubMed ID: 27249717 [TBL] [Abstract][Full Text] [Related]
19. Obstacles to Biosimilar Acceptance and Uptake in Oncology: A Review. Mroczek DK; Hauner K; Greene GJ; Kaiser K; Peipert JD; Golf M; Kircher S; Shaunfield S; Lylerohr M; Cella D JAMA Oncol; 2024 Jul; 10(7):966-972. PubMed ID: 38814582 [TBL] [Abstract][Full Text] [Related]
20. Similar names for similar biologics. Casadevall N; Felix T; Strober BE; Warnock DG BioDrugs; 2014 Oct; 28(5):439-44. PubMed ID: 25001080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]